Observational studyFrontiers in immunology2026
Neoadjuvant serplulimab combined with chemotherapy in locally advanced driver gene-negative squamous NSCLC: a multicenter observational study.
Nanlong Lin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.